Community Acquired Pneumonia Clinical Trial
Official title:
A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC 3781) Versus Oral Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia
This study evaluates the safety and efficacy of lefamulin, a pleuromutilin, for the treatment of adults with moderate community-acquired bacterial pneumonia
Lefamulin is a potent, semi-synthetic antibacterial belonging to a novel class known as the pleuromutilins. The oral dosage form of lefamulin is under investigation in this study. Lefamulin's in vitro antibacterial profile includes the most important bacterial pathogens causing respiratory tract infection (RTI). The antibacterial spectrum comprises S. pneumoniae, H. influenzae, M. catarrhalis, the atypical respiratory pathogens L. pneumophila, C. pneumoniae, and M. pneumoniae, S. aureus including MRSA and CA-MRSA, ß-haemolytic streptococci including S. pyogenes and S. agalactiae, and Enterococcus faecium including vancomycin-resistant enterococci (VRE). Moreover, as demonstrated in cross-resistance studies, lefamulin remains active against clinical isolates resistant to the following antimicrobial(s) (classes): macrolides, lincosamides, streptogramin B, oxazolidinones, tetracyclines, ß lactams, quinolones, trimethoprim-sulfametoxazole, mupirocin, and vancomycin. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02559310 -
Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia
|
Phase 3 | |
| Completed |
NCT01530763 -
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)
|
Phase 2/Phase 3 | |
| Completed |
NCT02517489 -
Community-Acquired Pneumonia : Evaluation of Corticosteroids
|
Phase 3 | |
| Not yet recruiting |
NCT01937832 -
A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
|
Phase 3 | |
| Completed |
NCT02454114 -
HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract Infections
|
N/A | |
| Completed |
NCT00653172 -
Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia
|
Phase 2 | |
| Recruiting |
NCT02139163 -
Epidemiological Study on Community Acquired Pneumonia
|
||
| Completed |
NCT03411824 -
Lung Ultrasound for Community-acquired Pneumonia Diagnosis in Emergency Medicine
|
||
| Recruiting |
NCT06210282 -
The Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in General Practice
|
N/A | |
| Withdrawn |
NCT02269644 -
A P3 Comparator Trial in Community Acquired Bacterial Pneumonia
|
Phase 3 | |
| Recruiting |
NCT01963442 -
Short Duration Treatment of Non-severe Community Acquired Pneumonia
|
Phase 2 | |
| Terminated |
NCT00887276 -
Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia
|
Phase 4 | |
| Not yet recruiting |
NCT00390819 -
Epidemiology of Community Acquired Pneumonia in North Israel
|
N/A | |
| Completed |
NCT00079885 -
Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia
|
Phase 3 | |
| Not yet recruiting |
NCT04158310 -
Evaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Children
|
||
| Recruiting |
NCT02552342 -
Corticosteroid Therapy for Severe Community-Acquired Pneumonia
|
Phase 4 | |
| Completed |
NCT02922387 -
Smoking Cessation Intervention in Respiratory Inpatients
|
Phase 4 | |
| Completed |
NCT00467701 -
Community Acquired Pneumonia in Telemark and Ostfold
|
N/A | |
| Completed |
NCT04198571 -
Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries
|
||
| Completed |
NCT02107001 -
Lung Ultrasound in Pleuritic Chest Pain
|
N/A |